Biogen Inc (BIIB) earnings · rev $9.89B
These earnings events as JSON? API free 100/dayBiogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
This BIIB earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B.
When the next BIIB 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 2.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BIIB research stays on the stock page; the tape stays on the quote page.
BIIB earnings FAQ
What are BIIB's latest revenue and net income?
Latest cached Biogen Inc (BIIB) revenue for Dec 31, 2025 was $9.89B. Net income was $1.29B. Statements: https://lician.com/financials/biib
What is BIIB's latest diluted EPS?
Latest cached Biogen Inc (BIIB) diluted EPS for Dec 31, 2025 was $8.79.
What period does the latest BIIB earnings print cover?
The latest cached Biogen Inc (BIIB) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BIIB revenue change from the prior cached period?
Cached Biogen Inc (BIIB) revenue was up 2.2% from $9.68B (Dec 31, 2024) to $9.89B (Dec 31, 2025). Statements: https://lician.com/financials/biib
Where are BIIB earnings listed?
Cached earnings facts for Biogen Inc (BIIB) are listed at https://lician.com/earnings/biib. Statements: https://lician.com/financials/biib
Not investment advice.